|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
All issues
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Lung and Thoracic cancer
A Randomized Phase II Study of
Irinotecan
Plus Cisplatin with or without Simvastatin in Ever-Smokers with Extended Disease Small Cell Lung Cancer
Youngjoo Lee, Soo-Hyun Lee, Geon Kook Lee, Eun Jin Lim, Ji-Youn Han
Cancer Res Treat.
2023;55(3):885-893. Published online March 20, 2023 DOI:
https://doi.org/10.4143/crt.2023.283
Pediatric cancer
Vincristine,
Irinotecan
, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults
Hee Young Ju, Meerim Park, Jun Ah Lee, Hyeon Jin Park, Seog Yun Park, June Hyuk Kim, Hyun Guy Kang, Hee Chul Yang, Byung-Kiu Park
Cancer Res Treat.
2022;54(2):563-571. Published online June 14, 2021 DOI:
https://doi.org/10.4143/crt.2021.178
Cited By 2
Characterization of Oncolytic Vaccinia Virus Harboring the Human
IFNB1
and
CES2
Transgenes
Euna Cho, S M Bakhtiar Ul Islam, Fen Jiang, Ju-Eun Park, Bora Lee, Nam Deuk Kim, Tae-Ho Hwang
Cancer Res Treat.
2020;52(1):309-319. Published online August 6, 2019 DOI:
https://doi.org/10.4143/crt.2019.161
Cited By 6
Randomized Phase III Trial of
Irinotecan
Plus Cisplatin versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients with Extensive-Disease Small Cell Lung Cancer
Dong-Wan Kim, Hoon-Gu Kim, Joo-Hang Kim, Keunchil Park, Hoon-Kyo Kim, Joung Soon Jang, Bong-Seog Kim, Jin-Hyoung Kang, Kyung Hee Lee, Sang-We Kim, Hun Mo Ryoo, Jin-Soo Kim, Ki Hyeong Lee, Jung Hye Kwon, Jin-Hyuk Choi, Sang Won Shin, Seokyung Hahn, Dae Seog Heo
Cancer Res Treat.
2019;51(1):119-127. Published online March 12, 2018 DOI:
https://doi.org/10.4143/crt.2018.019
Cited By 19
Randomized Open Label Phase III Trial of
Irinotecan
Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)
In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro
Cancer Res Treat.
2019;51(1):43-52. Published online February 14, 2018 DOI:
https://doi.org/10.4143/crt.2017.562
Cited By 32
Multicenter Phase II Study of Oxaliplatin,
Irinotecan
, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer
Changhoon Yoo, Boram Han, Hyeong Su Kim, Kyu-pyo Kim, Deokhoon Kim, Jae Ho Jeong, Jae-Lyun Lee, Tae Won Kim, Jung Han Kim, Dae Ro Choi, Hong Il Ha, Jinwon Seo, Heung-Moon Chang, Baek-Yeol Ryoo, Dae Young Zang
Cancer Res Treat.
2018;50(4):1324-1330. Published online January 8, 2018 DOI:
https://doi.org/10.4143/crt.2017.526
Cited By 19
Phase II Study of
Irinotecan
and Cisplatin Combination Chemotherapy in Metastatic, Unresectable Esophageal Cancer
Miso Kim, Bhumsuk Keam, Tae-Min Kim, Hoon-Gu Kim, Jin-Soo Kim, Sung Sook Lee, Seong Hoon Shin, Min Kyoung Kim, Keon Uk Park, Dong-Wan Kim, Hwan Jung Yun, Jong Seok Lee, Dae Seog Heo
Cancer Res Treat.
2017;49(2):416-422. Published online July 28, 2016 DOI:
https://doi.org/10.4143/crt.2016.121
Cited By 22
Irinotecan
Monotherapy Versus
Irinotecan
-Based Combination as Second-Line Chemotherapy in Advanced Gastric Cancer: A Meta-Analysis
Yo-Han Cho, So Young Yoon, Soo-Nyung Kim
Cancer Res Treat.
2017;49(1):255-262. Published online May 18, 2016 DOI:
https://doi.org/10.4143/crt.2015.452
Cited By 3
Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and
Irinotecan
-Based Chemotherapies
Min Jeong Lee, In Gyu Hwang, Joung-Soon Jang, Jin Hwa Choi, Byeong-Bae Park, Myung Hee Chang, Seung Tae Kim, Se Hoon Park, Myoung Hee Kang, Jung Hun Kang
Cancer Res Treat.
2012;44(4):235-241. Published online December 31, 2012 DOI:
https://doi.org/10.4143/crt.2012.44.4.235
Cited By 22
Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum,
Irinotecan
, and Taxane for Advanced Gastric Cancer
Ji Soo Park, Jae Yun Lim, Seung Kyo Park, Min Kyung Kim, Hee Sung Ko, Sun Och Yoon, Jong Won Kim, Seung Ho Choi, Jae Yong Cho
Cancer Res Treat.
2011;43(4):236-243. Published online December 27, 2011 DOI:
https://doi.org/10.4143/crt.2011.43.4.236
Cited By 15
Phase II Study of S-1 Plus Either
Irinotecan
or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment
Dal Yong Kim, Dae Ho Lee, Sun-Joo Jang, Sang-We Kim, Cheolwon Suh, Jung Shin Lee
Cancer Res Treat.
2011;43(4):212-216. Published online December 27, 2011 DOI:
https://doi.org/10.4143/crt.2011.43.4.212
Cited By 1
A Retrospective Study of First-Line Combination Chemotherapy in Advanced Colorectal Cancer: A Korean Single-Center Experience
Soon Il Lee, Se Hoon Park, Do Hyoung Lim, Keon Woo Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
Cancer Res Treat.
2011;43(2):96-101. Published online June 30, 2011 DOI:
https://doi.org/10.4143/crt.2011.43.2.96
Cited By 2
A Pilot Study of Cisplatin,
Irinotecan
, Leucovorin and 5-fluorouracil (PILF) Combination Chemotherapy for Advanced Gastric Cancer
Se Hoon Park, Soo Yeon Jeon, Kwang Il Ko, Eunmi Nam, Soo-Mee Bang, Eun Kyung Cho, Dong Bok Shin, Jae Hoon Lee, Woon Ki Lee, Min Chung
Cancer Res Treat.
2006;38(3):121-125. Published online June 30, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.3.121
Cited By 1
A Phase II Study of
Irinotecan
, 5-Fluorouracil and Leucovorin for Treatment in Patients with Previously Untreated Advanced Colorectal Cancer
Sang-Byung Bae, Nam-Su Lee, Han-Jo Kim, Kyoung-Ha Kim, Hyun-Jung Kim, Chan-Kyu Kim, Kyu-Taeg Lee, Sung-Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park
Cancer Res Treat.
2006;38(2):72-77. Published online April 30, 2006 DOI:
https://doi.org/10.4143/crt.2006.38.2.72
Cited By 3
Phase II Study of
Irinotecan
, 5-Fluorouracil, and Leucovorin in Relapsed or Metastatic Colorectal Cancer as First-line Therapy
Young-Woong Won, Young-Hyo Lim, Ho-Yong Park, Ho-Suk Oh, Jung-Hye Choi, Young-Yeul Lee, In-Soon Kim, Il-Young Choi, Myung-Ju Ahn
Cancer Res Treat.
2004;36(4):235-239. Published online August 31, 2004 DOI:
https://doi.org/10.4143/crt.2004.36.4.235
Cited By 5
Treatment of Small Cell Lung Cancer
Atsushi Horiike, Nagahiro Saijo
Cancer Res Treat.
2003;35(3):177-180. Published online June 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.3.177
Irinotecan
Combined with Bolus Fluorouracil, Continuous Infusion Fluorouracil, and Low-Dose Leucovorin Every Two Weeks in Patients with Oxaliplatin Pretreated Metastatic Colorectal Cancer
Hyuk Chan Kwon, Sung Hyun Kim, Jae Seok Kim, Hyo Jin Kim
Cancer Res Treat.
2003;35(2):135-140. Published online April 30, 2003 DOI:
https://doi.org/10.4143/crt.2003.35.2.135
Cited By 5
1
Journal Impact Factor 4.6